Ligand validation:6NH2

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6NH2_BTB_B_503	47%	79%	0.173	0.913	0.4	0.47	-	-	5	0	100%	1
6NH2_BTB_B_508	47%	45%	0.186	0.925	0.94	1.19	2	1	2	0	100%	1
6NH2_BTB_A_504	44%	59%	0.174	0.901	0.65	0.92	-	-	2	0	100%	1
6NH2_BTB_B_504	44%	62%	0.156	0.881	0.63	0.81	-	-	6	0	100%	1
6NH2_BTB_B_505	33%	80%	0.158	0.835	0.36	0.48	-	-	5	0	100%	1
6NH2_BTB_D_505	32%	53%	0.203	0.879	0.72	1.08	-	1	1	0	100%	1
6NH2_BTB_D_506	28%	67%	0.169	0.82	0.42	0.83	-	-	8	0	100%	1
6NH2_BTB_C_505	19%	27%	0.28	0.875	1.56	1.37	2	2	6	0	100%	1
6NH2_BTB_C_501	18%	32%	0.298	0.886	1.95	0.79	2	-	11	0	100%	1
6NH2_BTB_D_504	18%	72%	0.204	0.786	0.39	0.68	-	-	3	0	100%	1
6NH2_BTB_C_506	1%	86%	0.312	0.436	0.36	0.35	-	-	2	0	100%	1
9CWK_BTB_B_505	100%	80%	0.025	0.996	0.31	0.53	-	-	2	0	100%	1
9CW6_BTB_C_504	100%	51%	0.028	0.996	0.41	1.45	-	1	4	0	100%	1
9CW4_BTB_C_504	100%	49%	0.032	0.995	0.42	1.5	-	2	2	0	100%	1
9CW9_BTB_D_504	100%	70%	0.036	0.994	0.39	0.76	-	-	1	0	100%	1
5UOB_BTB_B_504	100%	73%	0.038	0.994	0.58	0.47	-	-	3	0	100%	1
5O5D_BTB_A_604	100%	59%	0.022	0.994	0.89	0.68	1	-	2	0	100%	1
8F9X_BTB_J_305	100%	60%	0.032	0.992	0.86	0.66	-	-	5	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.